Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07685730 · ClinicalTrials.gov registry record

Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight

A clinical trial, sponsored by Ohio State University.

Recruiting
Registry status
327
Enrollment target

NCT07685730 is a clinical trial that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 327 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07685730 is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
327 participants
Enrollment target

Study Summary

This is a single-center, prospective observational study in patients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia. It compares whether continuous noninvasive hemodynamic measurements from the lower extremity (toe) better predict neonatal outcomes than upper extremity (arm/finger) measurements during spinal-induced hypotension. Participants receive standard spinal anesthesia and routine blood pressure management, with additional monitoring using the ClearSight™ system at both upper and lower extremities from before spinal anesthesia through delivery. The primary outcome is a composite of neonatal outcomes (APGAR scores, need for respiratory support, cord gases, and NICU admission). Secondary outcomes include maternal side effects and comfort. Overall, the study evaluates whether lower-extremity hemodynamic monitoring improves detection of clinically relevant hypotension and prediction of neonatal outcomes compared to traditional arm measurements.

Interventions

  • DEVICE ClearSight

Trial Details

FieldValue
Enrollment Target 327 participants
Start Date 2025-02-06
Est. Completion 2029-08-06

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT07685730

The ClinicalTrials.gov registry entry for NCT07685730 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ClearSight is the first listed.

NCT07685730 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07685730 about?

NCT07685730 is a clinical study titled "Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight". This is a single-center, prospective observational study in patients undergoing cesarean delivery under spinal or combined spinal-epidural anesthesia. It compares whether continuous noninvasive hemodynamic measurements from the lower extremity (toe) better predict neonatal outcomes than upper extrem...

What is the current status of trial NCT07685730?

This trial is currently recruiting. The enrollment target is 327 participants. The study started on 2025-02-06. Estimated completion is 2029-08-06.

What interventions are being tested in trial NCT07685730?

The interventions under investigation include: ClearSight (DEVICE).

Who is sponsoring clinical trial NCT07685730?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.